“…In ALS SOD1 G93A mice, immune activation in the central nervous system (CNS) and peripheral nervous system is distinct compared to control animals, with an accumulation of multiple immune cell types associated with disease progression (Alexianu et al, 2001;Chiu et al, 2009). Specific immune cell populations such as CD4T cells may be protective (Beers et al, 2008), whereas others, such as neutrophils, inflammatory monocytes, CD8T cells and innate lymphoid cells, are destructive (Finkelstein et al, 2011;Murdock et al, 2017;Butovsky et al, 2012;Coque et al, 2019). In addition, the impact of the immune system may depend on the stage of disease, with protective cytokines, such as interleukin (IL)-4 and IL-10, expressed in the CNS during early disease, whereas pro-inflammatory cytokines, such as IL-6, tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ), are expressed during late disease (Henkel et al, 2006;Beers et al, 2011).…”